Diagnosis and management of immune thrombocytopenic purpura (ITP) remain largely
dependent on clinical expertise and observations more than on evidence derived from clinical …

Background: Despite an increase in the number of therapies available to treat patients with
immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist …

Cases of apparent secondary immune thrombocytopenia (ITP) after SARS-CoV-2 vaccination
with both the Pfizer and Moderna versions have been reported and reached public …

Over the last decade, there have been numerous developments and changes in treatment
practices for the management of patients with immune thrombocytopenia (ITP). This article is …

… Probably our results would not significantly modify the response rates reported by Arnold,
although significance and power of the analysis would improve, our series being the largest to …

The efficacy of convalescent plasma for coronavirus disease 2019 (COVID-19) is unclear.
Although most randomized controlled trials have shown negative results, uncontrolled studies …

Vaccine-induced immune thrombotic thrombocytopaenia (VITT) is a rare adverse effect of
COVID-19 adenoviral vector vaccines 1 , 2 – 3 . VITT resembles heparin-induced …

Background The epidemiology of thrombocytopenia in critically ill patients has not been
well characterized. The objective of this study was to systematically review the prevalence, …

Importance Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC)
and request elective surgery or procedure present a common clinical situation yet …

Background: Pilot trials are important to ensure that large randomized trials are rigorous,
feasible, and economically justifiable. The objective of this review is to highlight the importance …